BiotechTube
Home/TearSolutions/Anil C. Asrani
AC

Anil C. Asrani

President / CEO

TearSolutions

Therapeutic Areas

OphthalmologyOcular Surface Disease

TearSolutions Pipeline

DrugIndicationPhase
LacripepOcular Surface Disease / Dry Eye Disease (Primary Sjögren's Syndrome)Phase 2

Leadership Team at TearSolutions

GW
Gordon W. Laurie, PhD FARVO
Chief Scientific Officer / Co-founder
JN
James N. Cook
Chief Development Officer
CM
Colin M. Rolph
Chief Financial Officer
MG
Marc G. Odrich, MD
Chief Medical Officer / Medical Director
View full TearSolutions profile